Research and Markets has announced the addition of the "Breast Cancer - Pipeline Review, H1 2016" report to their offering.
Breast Cancer pipeline therapeutics constitutes close to 1127 molecules, out of which approximately 921 molecules are developed by Companies and the remaining by the Universities/Institutes. The author's latest report, "Breast Cancer - Pipeline Review, H1 2016," outlays comprehensive information on the therapeutics under development for breast cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Breast cancer is a kind of cancer that develops from breast cells. Breast cancer usually starts off in the inner lining of milk ducts or the lobules that supply them with milk. The risk factors of breast cancer includes age, beginning of periods before the age of twelve or going through menopause after the age of fifty-five, being overweight, using hormone replacement therapy, consumption of birth control pills and consumption of alcohol. The symptoms of breast cancer may include a lump in the breast, a change in size or shape of the breast or discharge from a nipple.
Treatment includes radiation, lumpectomy, mastectomy, chemotherapy and hormone therapy. The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 49, 143, 152, 2, 14, 464, 86 and 8 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical and Discovery stages comprises 12, 14, 1, 140 and 39 molecules, respectively.
Furthermore, this report also reviews of key players involved in therapeutic development for breast cancer and features dormant and discontinued projects.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/ktj32j/breast_cancer
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160831005709/en/Business Wire
Last updated on: 31/08/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.